Key Takeaways

Vyvanse Withdrawal Timeline

Vyvanse withdrawal can begin after a person stops taking Vyvanse or significantly reduces their dose after prolonged use. The FDA prescribing information states that withdrawal symptoms may occur after abrupt discontinuation or significant dose reduction following prolonged use of central nervous system stimulants, including Vyvanse (FDA, 2025).

Some people first experience a “crash,” which may include fatigue, low mood, increased appetite, brain fog and cravings. These symptoms may improve quickly, while some psychological symptoms may last longer. Broader psychostimulant withdrawal research describes acute withdrawal symptoms that can occur during early abstinence and protracted symptoms that may continue for weeks in some people (Li & Shoptaw, 2023).

The Vyvanse withdrawal timeline does not look the same for everyone. It can vary based on dose, length of use, dependence, mental health history and whether Vyvanse is stopped suddenly or tapered under medical supervision. Clinical guidelines for stimulant withdrawal emphasize individualized care and assessment based on each person’s physical, mental and social circumstances (ASAM/AAAP Clinical Guideline Committee, 2024).

 

Free, Confidential Helpline

Ready to take the next step toward recovery?

Our Recovery Advocates are available around the clock to answer your questions, verify your insurance, and help you find the right level of care — at no cost to you.

Call Us Now

(561) 340-7269

Available 24 hours a day, 7 days a week

Time After Last Dose

What May Happen

First 24 hours

Some people may begin to feel tired, foggy, irritable or emotionally low as the medication leaves the body.

24 to 36 hours

Symptoms may begin, including fatigue, depression, increased appetite, cravings, anxiety and difficulty focusing.

Days 2 to 5

Symptoms may become more noticeable. This period may include intense fatigue, mood swings, anxiety, insomnia, restlessness, cravings and low motivation.

Week 1

Physical symptoms may begin to improve for some people, but sleep issues, cravings, low mood and concentration problems may continue.

Weeks 2 and beyond

Some people continue to experience lingering psychological symptoms, such as low motivation, irritability, depression or cravings.

Because Vyvanse withdrawal can involve severe mood changes, cravings or psychiatric symptoms, people should speak with a healthcare provider before stopping or changing their dose (FDA, 2025; ASAM/AAAP Clinical Guideline Committee, 2024).

What Affects the Severity of Vyvanse Withdrawal?

Vyvanse withdrawal can be mild for one person and more difficult for another. Several factors can affect how long symptoms last and how intense they feel, including dose, duration of use, dependence, co-occurring mental health conditions and whether the medication is stopped abruptly or tapered under medical supervision (FDA, 2025; ASAM/AAAP Clinical Guideline Committee, 2024).

Factor

How It Can Affect Withdrawal

Dose

Higher doses may increase the risk of stronger withdrawal symptoms.

Length of use

Long-term use may make it harder for the body and brain to adjust after stopping.

Dependence

Physical or psychological dependence can make symptoms more intense.

How Vyvanse is stopped

Stopping suddenly may lead to stronger symptoms than tapering under medical supervision.

Mental health history

Depression, anxiety, ADHD or other conditions may complicate withdrawal.

Other substance use

Alcohol, drugs or other medications may affect withdrawal symptoms and safety.

Overall health

Sleep, nutrition, hydration and physical health can influence recovery.

Vyvanse Uses and Effects

Vyvanse is known generically as lisdexamfetamine. It is a prescription stimulant medication used to treat attention deficit hyperactivity disorder (ADHD) in adults and pediatric patients ages 6 and older. It is also prescribed to treat moderate to severe binge eating disorder in adults (FDA, 2025).

Vyvanse affects certain chemicals in the brain that help regulate attention, impulse control and activity levels. When taken as prescribed, it may help improve focus, reduce restlessness and support better symptom control in people with ADHD (FDA, 2025).

Vyvanse is a Schedule II controlled substance, meaning it has accepted medical uses but also carries a risk of misuse, abuse and dependence. It should only be taken under the supervision of a healthcare provider (FDA, 2025).

Common side effects of Vyvanse may include dry mouth, loss of appetite, weight loss, sleep problems, increased heart rate and jitteriness (FDA, 2025).

More serious side effects may include heart problems, increased blood pressure or heart rate, psychiatric adverse reactions, circulation issues and serotonin syndrome. Taking more Vyvanse than prescribed or using it in ways not directed by a doctor can increase the risk of serious complications, including overdose and death (FDA, 2025).

People with a history of heart disease, mental health conditions, circulation problems or drug and alcohol addiction should discuss these risks with a healthcare provider before taking Vyvanse (FDA, 2025).

Stopping Vyvanse: Crash vs. Withdrawal

A Vyvanse crash may happen as the medication wears off, while withdrawal is more likely to occur after stopping Vyvanse or significantly reducing the dose after prolonged use. The FDA label specifically describes withdrawal after abrupt discontinuation or dose reduction following prolonged use of CNS stimulants, including Vyvanse (FDA, 2025).

Vyvanse Crash

Vyvanse Withdrawal

Can happen when a dose wears off or is missed

Can happen after stopping or reducing Vyvanse after prolonged use

Often starts the same day

May begin after abrupt discontinuation or a significant dose reduction

Usually lasts for hours

May last several days to weeks, depending on the person

Symptoms may include fatigue, irritability, low mood, brain fog or increased appetite

Symptoms may include dysphoric mood, depression, fatigue, vivid unpleasant dreams, insomnia or hypersomnia, increased appetite and psychomotor changes

May happen even when Vyvanse is taken as prescribed

More likely with prolonged use, dependence, high doses, misuse or abrupt discontinuation

A crash is usually shorter, while withdrawal may last longer and may require medical guidance, especially if symptoms are severe or persistent (FDA, 2025; Li & Shoptaw, 2023).

Dependence and Its Impact on Withdrawal Symptoms

Dependence can develop when the body becomes used to functioning with Vyvanse. The FDA prescribing information states that Vyvanse may lead to physical dependence after prolonged use, even when taken as directed by a healthcare provider (FDA, 2025).

Misuse or abuse can increase the risk of dependence and withdrawal. This may include taking more Vyvanse than prescribed, using it without a prescription or taking it in ways not directed by a doctor (FDA, 2025).

People who are dependent on Vyvanse may experience stronger withdrawal symptoms. Severe stimulant-related psychiatric symptoms may include hallucinations, delusional thinking, mania, aggression or suicidal ideation, especially in the context of misuse, intoxication or psychiatric vulnerability (FDA, 2025; ASAM/AAAP Clinical Guideline Committee, 2024).

Medical supervision can help reduce these risks. A healthcare provider may recommend gradual dose changes and monitoring to help the body adjust more safely (FDA, 2025; ASAM/AAAP Clinical Guideline Committee, 2024).

Common Symptoms of Vyvanse Withdrawal

Vyvanse withdrawal can cause both physical and psychological symptoms. The FDA prescribing information lists withdrawal signs and symptoms after abrupt discontinuation or significant dose reduction following prolonged CNS stimulant use as dysphoric mood, depression, fatigue, vivid unpleasant dreams, insomnia or hypersomnia, increased appetite and psychomotor retardation or agitation (FDA, 2025).

Physical Symptoms

Physical symptoms of Vyvanse withdrawal may include fatigue, sleep changes, increased appetite, restlessness and psychomotor slowing or agitation (FDA, 2025). Broader psychostimulant withdrawal research also describes symptoms such as cravings and sleep disturbance during early and protracted withdrawal phases (Li & Shoptaw, 2023).

These symptoms can interfere with daily functioning. Medical assistance may help reduce discomfort and determine whether a higher level of care, such as detox or structured treatment, is needed (ASAM/AAAP Clinical Guideline Committee, 2024).

Psychological Symptoms

Vyvanse withdrawal can affect mood, motivation and mental health. Psychological symptoms may include dysphoric mood, depression, anxiety, irritability, poor concentration, low motivation, cravings and agitation (FDA, 2025; Li & Shoptaw, 2023).

In severe cases, stimulant-related psychiatric symptoms may include suicidal thoughts, hallucinations, paranoia or psychosis. These symptoms require immediate medical attention (FDA, 2025; ASAM/AAAP Clinical Guideline Committee, 2024).

Vyvanse Detox Treatment and Managing Withdrawal

Treatment focuses on reducing symptoms, improving safety and lowering the risk of relapse. The right approach depends on how long Vyvanse was used, the dose, whether it was misused and whether the person has co-occurring mental health symptoms (ASAM/AAAP Clinical Guideline Committee, 2024).

Vyvanse is an amphetamine-based stimulant, so withdrawal may share features with other forms of stimulant withdrawal, including fatigue, low mood, cravings and sleep changes (FDA, 2025; Li & Shoptaw, 2023). Medical support may include gradual dose changes, monitoring and symptom management rather than stopping suddenly without guidance (FDA, 2025; ASAM/AAAP Clinical Guideline Committee, 2024).

For people with more severe withdrawal symptoms or Vyvanse dependence, medical detox may be recommended. During detox, clinicians may monitor mood, sleep, appetite, cravings, energy levels and overall stability. They may also provide support for symptoms such as insomnia, anxiety, depression or agitation (ASAM/AAAP Clinical Guideline Committee, 2024).

Treatment may also include therapy or counseling to address cravings, emotional symptoms and relapse risks. Depending on the person’s needs, care may continue in a residential treatment, outpatient treatment, dual diagnosis program or rehab setting (ASAM/AAAP Clinical Guideline Committee, 2024; SAMHSA, 2021).

What Happens During Professional Detox?

Professional Vyvanse detox provides medical and emotional support while the body adjusts to the absence or reduction of the drug. Detox may be especially important for people with heavy use, long-term use, co-occurring mental health conditions or severe withdrawal symptoms (ASAM/AAAP Clinical Guideline Committee, 2024).

A professional program may include:

Medical assessment: A clinical team reviews the person’s Vyvanse use, health history, mental health symptoms and risk factors.
Tapering support: When appropriate, providers may gradually reduce the dose instead of stopping suddenly.
Monitoring: Staff may monitor mood, sleep, appetite, cravings, energy levels and overall stability.
Symptom management: Treatment may include support for insomnia, anxiety, depression, agitation or cravings.
Mental health support: Counseling and therapy can help address emotional symptoms and relapse risks.
Relapse prevention planning: Clients may begin learning coping skills and planning next steps for continued treatment.
Transition into ongoing care: Detox may be the first step before residential treatment, outpatient treatment, dual diagnosis care or rehab.

These components align with evidence-based recommendations for stimulant withdrawal and stimulant use disorder care, which emphasize individualized assessment, withdrawal management, behavioral treatment and linkage to ongoing care (ASAM/AAAP Clinical Guideline Committee, 2024; SAMHSA, 2021).

The Role of Therapy and Counseling

Therapy and counseling can help people manage cravings, mood changes, ADHD-related challenges and relapse risks during and after Vyvanse withdrawal. These services may be especially helpful for people experiencing depression, anxiety, low motivation or difficulty maintaining recovery (ASAM/AAAP Clinical Guideline Committee, 2024; SAMHSA, 2021).

Therapy may help people:

  • Understand triggers for Vyvanse misuse
  • Build healthier coping skills
  • Manage cravings
  • Address ADHD or other mental health symptoms
  • Improve relapse prevention strategies
  • Strengthen family and social support

Cognitive behavioral therapy may help people identify thought patterns and behaviors that contribute to substance use. Group therapy can also provide support from others working through similar challenges. Evidence-based behavioral approaches for stimulant use disorders include contingency management, cognitive behavioral therapy, community reinforcement and motivational interviewing (ASAM/AAAP Clinical Guideline Committee, 2024; SAMHSA, 2021).

Can You Quit Vyvanse Cold Turkey?

Stopping Vyvanse suddenly instead of gradually reducing the dose can increase the risk of uncomfortable or severe withdrawal symptoms, especially for people who have taken Vyvanse for a long time, used high doses or developed dependence. The FDA label states that withdrawal symptoms can occur after abrupt discontinuation or significant dose reduction following prolonged use of CNS stimulants, including Vyvanse (FDA, 2025).

Stopping Vyvanse suddenly may cause symptoms such as dysphoric mood, depression, fatigue, vivid unpleasant dreams, insomnia or hypersomnia, increased appetite and psychomotor slowing or agitation (FDA, 2025).

Abrupt discontinuation may also worsen ADHD symptoms or underlying mental health concerns. People taking Vyvanse should speak with a healthcare provider before stopping the medication (FDA, 2025).

To reduce the risk of withdrawal, people taking Vyvanse should:

  • Take Vyvanse only as prescribed.
  • Avoid changing the dose without medical guidance.
  • Use a tapering plan if recommended by a provider.
  • Get enough sleep.
  • Eat balanced meals and stay hydrated.
  • Avoid alcohol or other substances.
  • Seek help early if misuse, cravings or dependence develop.

These steps are consistent with prescribing guidance for medications with abuse and dependence potential and with clinical recommendations for individualized stimulant withdrawal management (FDA, 2025; ASAM/AAAP Clinical Guideline Committee, 2024).

When Should You Get Medical Help?

Some withdrawal symptoms can be managed with medical guidance, rest, hydration, nutrition and emotional support. However, certain symptoms may require immediate professional help (ASAM/AAAP Clinical Guideline Committee, 2024).

Seek medical help right away if you or a loved one experiences:

  • Thoughts of self-harm or suicide
  • Severe depression
  • Hallucinations or paranoia
  • Severe agitation or aggression
  • Confusion or disorientation
  • Intense cravings that increase relapse risk
  • Signs of a medical emergency, such as chest pain, irregular heartbeat, trouble breathing, fainting or loss of consciousness
  • Symptoms that are getting worse instead of better

If overdose is suspected, call 911 or seek emergency medical care immediately. If symptoms feel overwhelming or unsafe, contact a medical professional, local emergency services or a crisis support line. Severe psychiatric symptoms, cardiovascular symptoms and overdose concerns require urgent medical evaluation (FDA, 2025; ASAM/AAAP Clinical Guideline Committee, 2024).

Guidance on Seeking Help for Vyvanse Dependence

Vyvanse dependence can be difficult to manage without professional support. Help may be needed if a person feels unable to stop taking Vyvanse, takes more than prescribed, has cravings or experiences withdrawal symptoms when the medication wears off (FDA, 2025).

A healthcare provider can assess symptoms, review the person’s Vyvanse use and recommend the safest next steps. This may include monitored dose changes, medical detox, therapy, counseling or treatment for co-occurring mental health conditions (FDA, 2025; ASAM/AAAP Clinical Guideline Committee, 2024).

To reduce the risk of dependence or withdrawal, people taking Vyvanse should:

  • Take Vyvanse only as prescribed.
  • Avoid changing the dose without medical guidance.
  • Never share Vyvanse with anyone else.
  • Tell their provider about any history of substance misuse or abuse.
  • Report mood changes, side effects, cravings or signs of tolerance.
  • Store Vyvanse securely.
  • Attend regular medical check-ins.

These precautions are consistent with Vyvanse prescribing information, which warns about abuse, misuse, addiction and the need for monitoring during treatment (FDA, 2025).

Recovering From Drug Addiction

If you are struggling with a drug or alcohol addiction, it might be time for professional treatment. The experts at The Recovery Village Palm Beach at Baptist Health are able to identify and treat substance use disorders as well as other co-occurring mental health conditions. Contact us today to learn more about treatment programs that can work well for you.

FAQs

How long does Vyvanse withdrawal last?

Vyvanse withdrawal symptoms may occur after abrupt discontinuation or significant dose reduction following prolonged use of CNS stimulants, including Vyvanse. Symptoms can include dysphoric mood, depression, fatigue, vivid unpleasant dreams, insomnia or hypersomnia, increased appetite and psychomotor slowing or agitation. The timeline can vary depending on dose, duration of use, dependence, mental health history and whether the medication is stopped suddenly or adjusted with medical guidance (FDA, 2025; ASAM/AAAP Clinical Guideline Committee, 2024).

Can you quit Vyvanse cold turkey?

People should not stop Vyvanse suddenly without medical guidance, especially after long-term use, high-dose use or misuse. Stopping suddenly may increase the risk of withdrawal symptoms and may worsen ADHD or mental health symptoms (FDA, 2025; ASAM/AAAP Clinical Guideline Committee, 2024).

Why do I feel emotionally flat or unmotivated after stopping Vyvanse?

Some people feel emotionally flat, unmotivated or disconnected after stopping Vyvanse. Vyvanse is a CNS stimulant, and withdrawal after abrupt discontinuation or significant dose reduction may include dysphoric mood, depression and fatigue. These symptoms may also be related to untreated ADHD, depression or another underlying mental health condition. If emotional symptoms are severe or persistent, it is important to speak with a healthcare provider (FDA, 2025).

How can I tell the difference between Vyvanse withdrawal and ADHD symptoms returning?

Vyvanse withdrawal often includes symptoms such as dysphoric mood, depression, fatigue, increased appetite, sleep changes and psychomotor slowing or agitation. Returning ADHD symptoms may involve ongoing difficulty focusing, staying organized, completing tasks, managing time or maintaining attention. A healthcare provider can help determine whether symptoms are related to withdrawal, ADHD or another condition (FDA, 2025).

Does caffeine help with Vyvanse withdrawal?

Caffeine may temporarily increase alertness or energy for some people, but it is not a long-term treatment for Vyvanse withdrawal. Caffeine can also worsen anxiety, irritability, sleep problems or heart-related symptoms in some individuals. People experiencing Vyvanse withdrawal should speak with a healthcare provider before relying on caffeine or other stimulants, especially because stimulant medications can affect heart rate, blood pressure, anxiety and sleep (FDA, 2025).

Is it normal to feel better after restarting Vyvanse?

Some people may notice improved focus, energy or motivation after restarting Vyvanse as prescribed. However, Vyvanse should only be restarted, stopped or adjusted under the guidance of a prescribing healthcare provider (FDA, 2025).

References

ASAM/AAAP Clinical Guideline Committee. (2024). The ASAM/AAAP clinical practice guideline on the management of stimulant use disorder. Journal of Addiction Medicine, 18(1), 1–56. https://doi.org/10.1097/ADM.0000000000001299
 Full hyperlink: https://journals.lww.com/journaladdictionmedicine/fulltext/2024/05001/the_asam_aaap_clinical_practice_guideline_on_the.1.aspx

Li, M. J., & Shoptaw, S. J. (2023). Clinical management of psychostimulant withdrawal: Review of the evidence. Addiction, 118(4), 750–762. https://doi.org/10.1111/add.16093
 Full hyperlink: https://pubmed.ncbi.nlm.nih.gov/36401591/

Substance Abuse and Mental Health Services Administration. (2021). Treatment for stimulant use disorders (Treatment Improvement Protocol [TIP] Series, No. 33; SAMHSA Publication No. PEP21-02-01-004). U.S. Department of Health and Human Services.
 Full hyperlink: https://www.ncbi.nlm.nih.gov/books/NBK576541/

U.S. Food and Drug Administration. (2025). Vyvanse® (lisdexamfetamine dimesylate) prescribing information.
 Full hyperlink: https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021977s054,208510s011lbl.pdf